Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Synovial 1Sarcoma 1Neurofibrosarcoma 1Melanoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Dermatofibrosarcoma 1Carcinoma, Basal Cell 1

Interventions

Doxorubicin 3pembrolizumab 2pazopanib 2Radiotherapy 2Radiation 2Ifosfamide 2selinexor 1peposertib 1liposomal doxorubicin 1avelumab 1Specimen Handling 1Quality of Life 1Proton Therapy 1Nivolumab 1Magnetic Resonance Spectroscopy 1Immune Checkpoint Inhibitors 1Imatinib Mesylate 1Histamine H2 Antagonists 1Famotidine 1Dactinomycin 1Cyclophosphamide 1Blood Specimen Collection 1Biopsy 1BO-112 1Angptl4 protein, mouse 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dermatofibrosarcoma × BO-112 × 1 year × Clear all
NCT04420975 2026-03-10

Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma

Jonsson Comprehensive Cancer Center

Phase 1 Active not recruiting
14 enrolled
Sarcoma

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Dermatofibrosarcoma, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡